Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Proxalutamide
Sponsor: Suzhou Kintor Pharmaceutical Inc,
Collaborators: Peking University Cancer Hospital & Institute|Tianjin Medical University Cancer Institute and Hospital|Sun Yat-sen University|Ruijin Hospital|The First Affiliated Hospital with Nanjing Medical University|Hebei Medical University Fourth Hospital|Hunan Cancer Hospital